Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Combined With Radiation for Recurrent HNSCC
NCT07435415Phase 1Active, not recruiting
- Sponsor
- China Medical University Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of methylene blue in head and neck squamous cell carcinoma (HNSCC), sponsored by China Medical University Hospital. Primary endpoint: Severe Adverse Events at 1 year. Started Aug 2025; status: active, not recruiting.
02
Drugs
methylene blue
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07435415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435415.